We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boehringer Ingelheim invests € 70 million into its biopharmaceutical production plant in Biberach. This new investment is a move to strengthen the company's leading position in the development and manufacturing of biopharmaceuticals in the long term.
With Peru moving ever closer to agreeing a free trade agreement (FTA) with the US, there has been renewed criticism of the deal from non-governmental organisation (NGO) development bodies.
According to French health fund agency CNAM, health expenditure in the first nine months of the year rose 4.3%, compared to the same period last year, as government cost-containment measures failed to have the desired effect.
The US is planning to use World Trade Organisation (WTO) initiatives to pressure China into tightening up its intellectual property provisions and live up to its pledges to curb counterfeiting activity.
AstraZeneca Plc (AZN.L: Quote, Profile, Research) proved its reputation for above-average growth with a 49 percent jump in third-quarter earnings per share on Thursday, driven by a tight control of costs.
Biolex Therapeutics, a protein therapeutics company, and Kringle Pharma, Inc., a biopharmaceutical company developing cancer therapeutics, have formed a collaboration under which Biolex will use its LEX System(TM) for protein expression to create a commercial line for Kringle's NK4 protein.
Discovery Partners International, Inc. (Nasdaq: DPII) announced today that they have entered into a new drug discovery collaboration with Mitsubishi Pharma Corporation
(Mitsubishi) to discover lead compounds for a therapeutic target selected by Mitsubishi.